E

Ezhilarasan

Active Director Director DIN 02582388
DIN 02582388 First appointment May 2009 Primary industry Information Technology
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since May 2009
Shareholding value •••• Premium profile

About Ezhilarasan

Data last updated:

Ezhilarasan is a Director at Metacro-Ai Private Limited (since 2022), Director at Dr. V.R.E.Research Laboratories Private Limited (since 2009) and Director at Emvisante Health Care Private Limited (since 2024). The companies operate in Information Technology, Healthcare and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹18.1 Lakh; the largest is Metacro-Ai Private Limited at ₹17.6 Lakh (FY 2024). Earlier, Ezhilarasan was an Additional Director at Proqol Health Care Private Limited (2015) and Director at Whinlands Agro Private Limited (2016–2018) and 1 more.

DIN 02582388
Primary Designation Director
Industry Information Technology
First Appointment 06 May 2009
Oldest Company Age 17 yrs
Largest company Metacro-Ai Private Limited · ₹17.6 Lakh (FY 2024)
Combined revenue ₹18.1 Lakh across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Metacro-Ai Private Limited U72900TN2022PTC155287
Director12 Sep 20222022₹17.6 Lakh (FY 2024)Active
Director06 May 20092009₹45,225 (FY 2024)Active
Director26 Sep 20242024Under Process Of Striking Off

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Proqol Health Care Private Limited U52399TN2014PTC094755
Additional Director12 Jan 20152014₹31.67 Cr (FY 2025)Active
Whinlands Agro Private Limited U51909TN2016PTC110682
Director31 May 20162016Strike Off
Mirus Genomix Private Limited U85300TN2016PTC110606
Director26 May 20162016Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Ezhilarasan

Directorship timeline

Open interactive timeline →
Metacro-Ai Private Limited
Dr. V.R.E.Research Laboratories Private Limited
Mirus Genomix Private Limited
Emvisante Health Care Private Limited
Premium access

Shareholding and investment profile for Ezhilarasan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ezhilarasan

Ezhilarasan currently holds 3 directorships: Metacro-Ai Private Limited (Director, since 12 Sep 2022, revenue ₹17.6 Lakh (FY 2024)); Dr. V.R.E.Research Laboratories Private Limited (Director, since 06 May 2009, revenue ₹45,225 (FY 2024)); Emvisante Health Care Private Limited (Director, since 26 Sep 2024).

Ezhilarasan was first appointed on 06 May 2009 as Director at Dr. V.R.E.Research Laboratories Private Limited. The most recent appointment on record is 26 Sep 2024 at Emvisante Health Care Private Limited.

The 2 current companies of Ezhilarasan that report revenue have a combined latest revenue of ₹18.1 Lakh: Metacro-Ai Private Limited ₹17.6 Lakh (FY 2024); Dr. V.R.E.Research Laboratories Private Limited ₹45,225 (FY 2024).

Ezhilarasan held 3 earlier board appointments: Proqol Health Care Private Limited (Additional Director, 12 Jan 2015 to 30 Sep 2015); Whinlands Agro Private Limited (Director, 31 May 2016 to 02 May 2018); Mirus Genomix Private Limited (Director, from 26 May 2016).

The current boards of Ezhilarasan's companies include Santhi Ezhilarasan (Metacro-Ai Private Limited), Muthukrishnan Sathish (Emvisante Health Care Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available